logo-loader

Full interview: PetVivo preparing to bring their lead medical device Kush to market

Published: 18:46 01 Jun 2020 EDT

PetVivo (OTCQB: PETV) CEO John Lai joined Steve Darling from Proactive to discuss the company that is developing a treatment for osteoarthritis is horses and dogs. The company’s lead medical device is called Kush and according to PetVivo it mimics cartilage.

Lai tells Proactive about the size of the market for this application and when they plan on having available to veterinarians.

Xeris Biopharma Surpasses 2023 Expectations with Strategic Moves Poised for...

Xeris Biopharma CEO Paul Edick joined Steve Darling from Proactive to share news the company had a successful 2023, with a final tally of 164 million USD, which is at the upper end of their forecast. The company concluded the year with 72 million USD in cash, surpassing their initial projections...

8 hours, 41 minutes ago